Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload

Cardiovascular Research

Volumn 43, Issue 4, 1999, Pages 892-900

  Bartfay, Wally J ^a   Dawood, Fayez ^a   Wen, Wen H ^a   Lehotay, Denis C ^a   Hou, David ^a   Bartfay, Emma ^b   Luo, Xiaoping ^c   Backx, Peter H ^a   Liu, Peter P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Aldehydes; Cardiac function; Free radicals; Heart failure; Iron overload; Mice

Indexed keywords

ALDEHYDE; FREE RADICAL; IRON; IRON DEXTRAN; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; HEART; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; IRON OVERLOAD; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ALDEHYDES; ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; IRON; IRON OVERLOAD; MALE; MICE; MICE, INBRED STRAINS; MYOCARDIUM; PERFUSION; RANDOM ALLOCATION; VENTRICULAR PRESSURE;

EID: 0032853734     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00040-1     Document Type: Article

References (73)

1. Liu P., Olivieri N. Iron overload cardiomyopathies: new insights into an old disease. Cardiovasc Drugs Ther. 8:1994;101-110.
2. Aldouri M.A., Hoffbrand A.V., Flynn D.M., et al. High incidence of cardiomyopathy in beta-thalassemia patients receiving regular transfusions and iron chelation: reversal by intensified chelation. Acta Haematol. 84:1994;113-123.
3. Hou J.W., Wu M.H., Lin K.H., Lue H.C. Prognostic significance of left ventricular diastolic indexes in beta-thalassemia major. Arch Ped Adolescent Med. 148:1994;862-866.
4. Engle M.A., Erlandson M., Smith C.H. Late cardiac complications of chronic, severe, refractory anemia with hemochromatosis. Circulation. 30:1964;698-705.
5. McCord J.M. Effects of positive iron status at a cellular level. Nutr Rev. 54:1996;85-88.
6. Lesnefsky E.J. Tissue iron overload and mechanisms of iron-catalyzed oxidative injury. Adv xp Med Biol. 366:1994;129-146.
7. Herbert V., Shaw S., Jayatilleke E., Stopler-Kasdan T. Most free-radical injury is iron meditated: it is promoted by iron, hemin, holoferritin and vitamin C., and inhibited by desferoxamine and apoferritin. Stem Cells. 12:1994;289-303.
8. Burkitt M.J., Kadiiska M.B., Hanna P.M., Jordan S.L., Mason R.P. Electron spin resonance spin-trapping investigation into the effects of paraquat and desferrioxamine on hydroxyl radical generation during acute iron poisoning. Mol Pharmacol. 43:1992;257-263.
9. Burkitt M.J., Mason R.P. Direct evidence for in vivo hydroxyl radical generation in experimental iron overload: an ESR spin-trapping investigation. Proc Natl Acad Sci USA. 88:1991;8440-8444.
10. Grootveld M., Bell J.D., Halliwell B., et al. Non-transferrin bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem. 264:1989;4417-4422.
11. Wang W.C., Asmed N., Hanna M. Non-transferrin-bound iron in long-term transfusion in children with congenital anemias. J Pediatrics. 108:1986;552-557.
12. Gutteridge J.M.C., Rowley D.A., Griffiths E., Halliwell B. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci. 68:1985;463-467.
13. Hershko C., Graham G., Bates G.W., Rachmilewitz E.A. Non-specific serum iron in thalassemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol. 40:1978;255-268.
14. Livrea M.A., Tesoriere L., Pintaudi A.M., et al. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood. 88:1996;3608-3614.
15. Young I.S., Trouton T.G., Torney J.J., McMaster D., Callender M.E., Trimble E.R. Antioxidant status and lipid peroxidation in hereditary haemochromatosis. Free Radical Bio Med. 16:1994;393-397.
16. Parkkila S., Niemela O., Britton R.S., et al. Vitamin E decreases hepatic levels of aldehyde-derived peroxidation products in rats with iron-overload. Am J Physiol. 270:1996;G376-G384.
17. Figueiredo M.S., Baffa O., Barbieri Neto J., Zago M.A. Liver injury and generation of hydroxyl free radicals in experimental secondary hemochromatosis. Res Exp Med. 193:1993;27-37.
18. Houglum K., Filip M., Witzutum B., Choiker M. Malondialdehyde and 4-hydroxynoneal protein adducts in plasma and liver of rat with iron overload. J Clin Invest. 86:1990;1991-1998.
19. Olfert E.D., Cross B.M., McWilliam A.A. Canadian Council on Animal Care. Guide to the care and use of experimental animals. 1993;Bradda Printing Services, Ottawa, Ontario.
20. Bartfay W.J., Hou D., Brittenham G.M., et al. The synergistic effects of vitamin E and selenium in iron-overloaded mouse hearts. Can J Cardiol. 14:1998;937-941.
21. Bartfay W.J., Lehotay D.C., Olivieri N., et al. The cardioprotective effects of selenium, morin hydrate, and vitamin E in a murine model of iron overload cardiomyopathy. Can J Cardiol. 13:1997;84C. (Abstract).
22. Liu P., Henkelman R.M., Joshi J., et al. Quantification of tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia cardiac iron overload model. Can J Cardiol. 12:1996;155-164.
23. Brooks W.W., Apstein C.S. Effect of treppe on isovolumic function in the isolated blood-perfused mouse heart. J Mol Cell Cardiol. 28:1996;1817-1822.
24. Grupp I.L., Subramaniam A., Hewett T.E., Robbins J., Grupp G. Comparison of normal hypodynamic and hyperdynamic mouse hearts using isolated work- performing heart preparations. Am J Physiol (Heart Cir Physiol). 34:1993;H1401-H1410.
25. Ng W.A., Robbins J., Subramaniam A., Grupp I.L. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res. 68:1991;1742-1750.
26. Doring H.J., Dehnert H. The isolated perfused heart according to Langendorff. 1987;Biomesstechnik-Verlag March, March, West Germany.
27. Baim D.S., Grossman W. Cardiac catherization, angiography, and intervention. 5th ed :1996;Williams & Wilkins, Philadelphia, Pennsylvania.
28. Yazdanpanah M., Luo X.P., Lau R., et al. Cytotoxic aldehydes as possible markers for childhood cancer. Free Rad Biol Med. 23:1997;870-878.
29. Luo X.P., Yazdanpanah M., Bhooi N., Lehotay D.C. Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry. Anal Biochem. 228:1995;294-298.
30. Link G., Athias P., Grynberg A., Hershko C., Pinson A. Iron loading modifies beta-adrenergic responsiveness in cultured ventricular myocytes. Cardioscience. 2:1996;185-188.
31. Vernon D.D., Banner W. Jr., Dean J.W. Hemodynamic effects of experimental iron poisoning. Ann Emerg Med. 18:1989;863-866.
32. Artman M., Olsen R.D., Boucek R.J. Jr., Ghishan F.K., Boirth R.C. Acute effects of iron on contractile function in isolated rabbit myocardium. Dev Pharmacol Ther. 7:1984;50-60.
33. Pucheu S., Coudray C., Tresallet N., Favier A., de Leiris J. Effect of iron overload in the isolated ischemic and reperfused rat heart. Cardiovasc Drugs Ther. 7:1993;701-711.
34. Link G., Pinson A., Hersko C. Heart cells in culture: a model of myocardial iron overload and chelation. J Lab Clin Med. 106:1985;147-153.
35. Randell E.W., Parkes J.G., Olivieri N.F., Templeton D.M. Uptake of nontransferrin-bound iron by both reductive and nonreductive processes is modulated by intracellular iron. J Biol Chem. 269:1994;16046-16053.
36. Kaplan J., Jordan I., Sturrock A. Regulation of the transferrin-independent iron transport system in cultured cells. J Biol Chem. 266:1991;2997-3004.
37. Parkes J.G., Hussain R.A., Olivieri N.F., Templeton D.M. Effects of iron loading on uptake, speciation, and chelation of iron in cultured myocardial cells. J Lab Clin Med. 122:1993;36-47.
38. Olsen L.J., Edwards W.D., McCall J.T., Ilstrup D.M., Gersh B.J. Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. J Am Coll Cardiol. 10:1987;1239-1243.
39. Meneghini R. Iron homeostasis, oxidative stress, and DNA damage. Free Radic Biol Med. 23:1997;783-792.
40. Lucesoli F., Fraga C.G. Oxidative damage to lipids and DNA concurrent with decrease of antioxidants in rat testes after acute iron intoxication. Arch Biochem Biophys. 316:1995;567-571.
41. 4 on electrical and mechanical activity of guinea pig papillary muscles. Chung-Kuo-Yao-Li-Hsuesh-Pao. 10:1989;523-525.
42. Winegar B.D., Kelly R., Lansman J.B. Block of current through single calcium channels by Fe Co and Ni. J Gen Physiol. 97:1991;351-367.
43. Kim E., Giri S.N., Pessah I.N. Iron (II) is a modulator of ryanodine-sensitive calcium channels of cardiac muscle sarcoplasmic reticulum. Toxicol Applied Pharmacol. 130:1995;57-66.
44. Britton R.S., O'Neill R., Bacon B.R. Chronic dietary iron overload in rats results in impaired calcium sequestration by hepatic mitochondria and microsomes 1,2, and 3. Gastroenterology. 101:1991;806-811.
45. Stohs S.J., Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Rad Biol Med. 18:1995;321-336.
46. Orrenius S., Burkitt M.J., Kass G.E.N., Dypburk J.M., Nicotera P. Calcium ion and oxidative cell injury. Ann Neurol. 32:1992;S33-S42.
47. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr. 57:1993;779S-786S.
48. Dianzani M.U., Paradisi L., Parola M., Barrera G., Rossi M.A. Action of the aldehydes derived from lipid peroxidation on isolated liver plasma membranes. Crastes de Paulet A., Douste-Blazy L., Paoletti R. Free radicals, lipoproteins, and membrane lipids. 1990;171-181 Plenum Press, New York.
49. Grune T., Siems W.G., Zollner H., Esterbauer H. Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in Ehrlich mouse ascites cells at different proliferation stages. Cancer Res. 54:1994;5231-5235.
50. VanWinkle W.B., Snuggs M., Miller J.C., Buja L.M. Cytoskeletal alterations in cultured cardiomyocytes following exposure to the lipid peroxidation product, 4-hydroxynonenal. Cell Mobil Cytoskeleton. 28:1994;119-134.
51. 2+ -pump dysfunction in rat cardiomyocytes briefly exposed to hydroxyl radicals. Free Rad Biol Med. 22:1996;37-47.
52. Kaneko M., Matsumoto Y., Hayashi H., Kobayashi A., Yamazaki N. Oxygen free radicals and calcium homeostasis in the heart. Mol Cell Biochem. 139:1994;91-100.
53. 2+ pump by oxygen free radicals. Am J Physiol. 257:1989;H804-H811.
54. Nicotera P., Orrenius S. The role of calcium in apoptosis. Cell Calcium. 23:1998;173-180.
55. Lipton S.A., Nicotera P. Calcium, free radicals and excitoxins in neuronal apoptosis. Cell Calcium. 23:1988;165-171.
56. Link G., Pinson A., Hershko C. Iron loading of cultured cardiac myocytes modifies sarcolemmal structure and increases lysosomal fragility. J Lab Clin Med. 121:1993;127-134.
57. Singal P.K., Dhalla A.K., Hill M., Thomas T.P. Endogenous antioxidant changes in the myocardium in response to acute and chronic stress conditions. Mol Cell Biochem. 129:1993;179-186.
58. Kukreja R.C., Hess M.L. The oxygen free radical system: from equations through membrane/protein interactions to cardiovascular injury and protection. Cardiovas Res. 26:1992;641-655.
59. Van der Kraaij A.M.M., Mostert L.J., Van Eijk H.G., Koster J.F. Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by antioxidant (+)-cyanidanol-3 and deferoxamine. Circulation. 78:1988;443-449.
60. Bolli R., Patel B.S., Zhu W.X., et al. The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction. Am J Physiol. 253:1987;H1372-H1380.
61. Menasche P., Grousset C., Gaudel Y., Mouas C., Piwnica A. Prevention of hydroxyl radical formation: a critical concept for improving cardioplegia. Protective effects of deferoxamine. Circulation. 76:(Supp V):1987;906-915.
62. Bastist G., Norton J., Katki A.G., et al. Cardiac and red blood cell glutathione peroxidase: results of a prospective randomized trail in patients on total parenteral nutrition. Cancer Res. 45:1985;5900-5903.
63. Marklund S.L., Westgate N.G., Lundgren E., Roos G. Copper-and zinc-containing superoxide dismutase, maganese-containing superoxide dismutase, catalase and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res. 42:1982;1955-1961.
64. Voodg A., Koster J.F., van Eijk H.G., Sluiter W. Low molecular weight iron and the oxygen paradox in isolated rat hearts. J Clin Invest. 90:1992;2050-2055.
65. Ozaki M., Kawabata T., Awai M. Iron release from haemosiderin and production of iron-catalyzed hydroxyl radicals in vitro. Biochem J. 250:1988;589-595.
66. Bannister J.V., Bannister W.H., et al. The effect of ferritin iron loading on hydroxyl radical production. Life Chem Rep. 84:(Suppl 2):1984;64-72.
67. Reif D.W. Ferritin as a source of iron for oxidative damage. Free Rad Biol Med. 12:1992;417-427.
68. Biemond P., Swaak A.J., Beindorff C.M., Koster J.F. Superoxide-dependent and/-independent mechanisms of iron mobilization from ferritin by xanthine oxidase Implications for oxygen-free-radical-induced tissue destruction during ischaemia and inflammation. Biochem J. 239:1986;169-173.
69. Thomas C.E., Morehouse L.A., Aust S.D. Ferritin and superoxide-dependent lipid peroxidation. J Biol Chem. 260:1985;3275-3280.
70. Mao G.D., Thomas P.D., Lopaschuk G.D., Poznansky M.J. Superoxide dismutase (SOD)-catalase conjugates. Role of hydrogen peroxide and the Fenton reaction in SOD toxicity. J Biol Chem. 268:1993;416-420.
71. Madani T.A.A., Bormanis J. Reversible severe hereditary hemochromatic cardiomyopathy. Can J Cardiol. 13:1997;391-394.
72. Olivieri N.F., Berriman A.M., Tyler B.J., et al. Reduction in tissue iron stores with a new regimen of continuous ambulatory intravenous deferoxamine. Am J Hematol. 41:1992;61-63.
73. Rahko P.S., Salerni R., Uretsky B.F. Successful reversal by chelation therapy of congestive cardiomyopathy due to iron overload. J Am Coll Cardiol. 8:1986;436-440.